Abstract
This is the second of a two-part overview of the fundamentals of oncology for interventional radiologists. The first part focused on clinical trials, basic statistics, assessment of response, and overall concepts in oncology. This second part aims to review the methods of tumor characterization; principles of the oncology specialties, including medical, surgical, radiation, and interventional oncology; and current treatment paradigms for the most common cancers encountered in interventional oncology, along with the levels of evidence that guide these treatments.
Original language | English (US) |
---|---|
Pages (from-to) | 1157-1164 |
Number of pages | 8 |
Journal | Journal of Vascular and Interventional Radiology |
Volume | 24 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2013 |
Funding
R.S. is supported in part by National Institutes of Health Grant CA126809. D.Y.S. serves on the scientific advisory boards of Jennerex Biotherapeutics (San Francisco, California), Surefire Medical (Westminster, Colorado), Treus Medical (Redwood City, California), Radguard (Los Altos, California), and Lunar Design (San Francisco, California); is a member of the speaker’s bureau of WL Gore and Associates (Flagstaff, Arizona); and is a paid consultant for BTG (West Conshohocken, Pennsylvania) and Sirtex (North Sydney, Australia). R.J.L. serves on the scientific advisory boards of Surefire and Nordion (Ottawa, Ontario, Canada). R.S. serves on the scientific advisory board and is a paid consultant for Bristol-Myers Squibb (New York, New York), Abbott (Santa Clara, California), Bayer/Onyx (Leverkusen, Germany), National Comprehensive Cancer Network, Merit Medical (South Jordan, Utah), BTG, Nordion, Sirtex, and Boston Scientific (Natick, Massachusetts). None of the other authors have identified a conflict of interest.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging